Mondaq All Regions: Intellectual Property > Patent
McCarthy Tétrault LLP
On August 21, 2019, the Government of Canada published amendments to the Patented Medicines Regulations that set out the long-awaited framework applicable to the price regulation of patented drugs in Canada.
Khurana and Khurana
A Patent infringement lawsuit was filed by Communication Components Antenna INC against alleged infringer Ace Technologies Corp and its related entities and subsidiaries in relation to its patent which was titled...
Singh & Associates
Internet of Things or IoT is an approach to interrelating computer devices, objects, digital and mechanical machines, automobile and animals or humans.
Singh & Associates
Under Trade-Related Aspects of Intellectual Property Rights (TRIPS)' there was no access to medicines for underdeveloped countries for treating serious health issues.
Khurana and Khurana
Recently, Huawee's demand for 1 billion USD as license fee from Verizon Inc captured interest of almost every patent enthusiast around the globe.
Saint Island International Patent & Law Offices
At the beginning of January 2018, a patent linkage system was promulgated and introduced into the Pharmaceutical Affairs Act.
Marks & Clerk
Welcome to the latest edition of Business Intelligence. To view the online version of this magazine, please follow this link.
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
In Solutran, Inc. v. Elavon, Inc., Nos. 2019-1345, -1460 (Fed. Cir. July 30, 2019), the Federal Circuit reversed the district court's patent-eligibility finding and held Solutran's U.S. Patent No. 8,311,945 not patent...
Fish & Richardson PC
This post continues our monthly summary of patent litigation in the District of Minnesota, including short summaries of various substantive orders issued in pending cases
Wolf, Greenfield & Sacks, P.C.
In view of Applicant OEP's own utility patent, the Board had no doubt in affirming a Section 2(e)(5) functionality refusal of the product configuration shown below, for umbrellas.
Ropes & Gray LLP
Keeping with yesterday's discussion of Patent Trial & Appeal Board (PTAB) estoppel in the district courts, a decision from earlier this year on yet another aspect of this estoppel has been recalibrated.
Holland & Knight
The Federal Circuit – in a split decision – remanded a recent N.D. California decision and held that the district court should have construed a disputed
Ropes & Gray LLP
District courts continue to grapple with whether or not physical products described by prior art publications of an earlier Patent Trial & Appeal Board (PTAB) trial are subject to estoppel.
Akin Gump Strauss Hauer & Feld LLP
On remand from the Court of Appeals for the Federal Circuit, the Patent Trial and Appeal Board granted patent owner's motion to amend on the basis that the totality of the record
Wolf, Greenfield & Sacks, P.C.
The Board affirmed a Section 2(e)(5) refusal to register the product configuration shown below, for "yoga blocks," finding the proposed mark to be de jure functional and therefore
BakerHostetler
The Trump administration, addressing efforts to curb online counterfeiting, has called for heightened collaboration, at times suggesting providing private parties with technological resources to help combat online counterfeiting.
BakerHostetler
Late last week, a major U.S. financial services firm made headlines with several blockchain-related developments. The first relates to a credit card that will be offered
BakerHostetler
In two opinions issued in the past few weeks, the Federal Circuit has shaken up two requirements of the reissue statute that most practitioners don't think about much.
Mintz
In a decision from the PTAB issued last week, the Board confirmed that the "enhanced estoppel" provision of 35 U.S.C. § 315(e)(1) applies to co-pending IPR proceedings when a final written decision issues in a first IPR.
Ropes & Gray LLP
That really ties the hands of plans trying to get lower prices because they can't exclude similar drugs just because they're expensive.
Latest Video
Most Popular Recent Articles
Hausfeld
Endo's patent litigation against Impax continued, and the trial commenced June 3, 2010.
Cooley LLP
As 2019 kicks off, the Cooley antitrust group highlights 10 recent developments and trends corporate counsel should be aware of – from the US Supreme Court and lower courts, the DoJ and FTC ...
Bennett Jones LLP
After 13 months of negotiations, the United States, Mexico and Canada have concluded the United States-Mexico-Canada Agreement (USMCA).
Borden Ladner Gervais LLP
The United States is often the largest target market for Canadian innovators, but exceptions to patentability extended by U.S. courts in recent years have made it difficult for innovators to obtain
Haseltine Lake Kempner LLP
On 1 February 2019 the UK IPO issued a notice that brings welcome news for biotech innovators wanting to use the services of the UK IPO.
Lewis Brisbois Bisgaard & Smith LLP
In a curious legal scenario, the USPTO recently filed an amicus brief at the request of the Federal Circuit Court of Appeals, supporting a "counterintuitive" reading of the American Invents Act (AIA).
Dennemeyer Group
The term "trade secret" is invariably included in any definition of "Intellectual Property." However, while the majority of IP types are subject to strict rules
HGF Ltd
The decision of case G01/18 has recently been published in French by the EPO's Enlarged Board of Appeal (EBoA).
Smart & Biggar/Fetherstonhaugh
On June 28, 2019, the Federal Court of Appeal granted the appeal of the Patented Medicine Prices Review Board (PMPRB or Board) and returned to the Board the matter of whether the invention of the 237
Dennemeyer Group
Private sector research and development (R&D) funding remains concentrated.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter